Loading market dashboard
Trulieve Cannabis Corp.
TCNNFHealthcareOTCUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Green Thumb Industries and Tilray are in a strong position to benefit from the reclassification of cannabis as a Schedule III drug. Tilray is well positioned to expand its U.S. operations.
Subordinate Voting Shares expected to begin trading under ticker "TRLV" on Wednesday, June 10 TALLAHASSEE, Fla., June 5, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that its subordinate voting shares (the "Subordinate Voting Shares") have been approved for listing on the New York Stock Exchange ("NYSE").
As June 2026 begins, cannabis investors continue searching for companies with strong operations and improving profitability. Although the industry still faces regulatory challenges, many leading operators have strengthened their balance sheets. Additionally, several companies continue generating significant revenue despite difficult market conditions.
The post-280E era will usher in new winners among cannabis stocks.
The cannabis industry once again is going through some big changes. Nearly every state in the USA has some form of legal cannabis legislation. Now, with the recent passing of cannabis being considered a class 3 substance, companies are preparing for the future. This preparation is making the necessary adjustments for businesses to take advantage of this new law. Some companies are forming partnerships to evolve further and take their place at the forefront of the sector.
Trulieve is looking at the possibility of uplisting its stock. The company will benefit from the rescheduling of medical cannabis. Trulieve recently reported in-line Q1-2026 financial performance.
TALLAHASSEE, Fla., May 13, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that the Company will be seeking shareholder approval of a proposed plan of arrangement (the "Arrangement") which involves the continuance of the Company out from the province of British Columbia, Canada, and the concurrent domestication of the Company to the State of Delaware in the United States (the "Domestication").
Trulieve Cannabis Corp. (TCNNF) Q1 2026 Earnings Call Transcript
First quarter revenue of $287 million, with 59% gross margin Positive net income of $2 million and Adjusted EBITDA of $100 million* Rescheduling of medical marijuana to Schedule III enabled applications for DEA registration TALLAHASSEE, Fla., May 7, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced its results for the quarter ended March 31, 2026.
New Marion County location will host grand opening celebration Friday, May 8 TALLAHASSEE, Fla., May 5, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S, today announced the opening of a new medical cannabis dispensary in Belleview, Florida.
The cannabis industry in the United States is entering a new phase of sustained growth, positioning itself as one of the most closely watched emerging sectors for both investors and industry professionals. As legalization continues to expand at the state level, the legal framework supporting the cannabis industry is becoming stronger and more normalized. With only a handful of states yet to adopt full medical or adult-use programs, cannabis is approaching near-national acceptance, significantly increasing the total addressable market.
Trulieve is the largest multi-state operator in the U.S., with more than 200 dispensaries. Green Thumb is the rare profitable pure-play cannabis company.
Cannabis stocks have seen renewed investor interest as federal policy momentum improves. The most important recent development was the placement of FDA-approved marijuana products and state-regulated medical marijuana products from Schedule I to Schedule III under the Controlled Substances Act.
TALLAHASSEE, Fla., April 29, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that it has filed applications with the U.S. Drug Enforcement Administration (DEA) to register certain state‑licensed medical marijuana operations pursuant to the expedited registration pathway established by the recent rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.
Marijuana rescheduling can result in significant tax savings for multi-state operators (MSOs) in the U.S. Three of the largest MSOs are Curaleaf Holdings, Green Thumb Industries, and Trulieve Cannabis. These are among the better-run cannabis companies in the entire industry, and they could be among the biggest winners from marijuana reform.
Rescheduling is a positive milestone for the marijuana industry. It doesn't, however, legalize marijuana or mean that every pot stock will benefit from the news.
On the heels of the executive order to fast-track research into psychedelic drugs, a second major federal policy shift on April 23, 2026, is sending waves through the cannabis sector. However, the real catalyst is being widely misunderstood by many on Wall Street.
Reclassification Enables Research and Supports State Licensed Medical Marijuana Operators TALLAHASSEE, Fla., April 23, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., applauds the rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.
Trulieve Cannabis rallies on renewed hopes for U.S. cannabis rescheduling, but regulatory uncertainty persists. The cannabis MSO remains fundamentally strong with $1.18B revenue, $427M adjusted EBITDA (36% margin), and robust cash flow, despite a $668M uncertain tax liability. Removal of the 280E tax burden could unlock significant upside, but timing and financial impact remain unclear.
The U.S. cannabis industry continues to grow, even with ongoing challenges. Demand remains strong across both medical and adult-use markets. At the same time, pricing pressure continues to impact margins in several states.
TALLAHASSEE, Fla., April 17, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., will hold a conference call on Thursday, May 7, 2026 at 8:30 AM Eastern Time following the release of its first quarter 2026 financial results.
New Leon County location will host grand opening celebration Monday, April 20 TALLAHASSEE, Fla., April 17, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S, today announced the opening of a new medical cannabis dispensary in Tallahassee, Florida.
At this time, the cannabis industry is growing at a fast pace. More companies are building and collaborating with other players in the industry to enhance their operations further. In the United States, cannabis regulations and operational guidelines in legal markets are still being updated and improved. Even though the development of a better industry has left the public sector with high levels of volatility.
New Glades Road location will host grand opening celebration Friday, April 24 TALLAHASSEE, Fla., April 13, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S, today announced the opening of a new medical cannabis dispensary in Boca Raton, Florida.
New Tampa Bay area location will host grand opening celebration Friday, April 24 TALLAHASSEE, Fla., April 10, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S, today announced the opening of a new medical cannabis dispensary in Lutz, Florida on Saturday, April 11.
The U.S. cannabis sector continues to show strong long-term growth potential. The market is expected to expand significantly over the next several years. However, short-term volatility continues to affect stock performance across the sector. At the same time, investors are closely watching developments in federal reform. In addition, rescheduling discussions continue to support bullish sentiment. Meanwhile, state-level expansion remains strong across key markets.
Marijuana stock investors have a strong focus on long-term investing. At this time, the changes being made in the cannabis industry have led to a downtrend and high volatility for the sector. Nevertheless, legal operators in most regions are making money and progressing as a business. For those cannabis companies that are publicly traded, it gives people a chance to profit as well.
We will go over some of the better ways to look at and gauge how to invest in the best marijuana stocks. Before anything, I want to research and learn about the companies in the space and which ones are publicly traded. Not all cannabis companies are public yet, and at times, this can also impact how pot stocks trade. There is a large amount of speculation, so being aware of unexpected changes is a big part of being a marijuana stock trader.
The U.S. cannabis sector continues evolving as legalization momentum builds. Additionally, companies are focusing on profitability and operational efficiency. Many investors are watching multi-state operators for growth opportunities. Furthermore, industry consolidation could create stronger long-term leaders.
TALLAHASSEE, Fla., March 17, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that effective as of March 17, 2026, Ms.
The success of the cannabis industry has brought in a crowd of new marijuana stock investors. Many feel that with all that is going on and the growing acceptance of legal cannabis, money can be made. So rather than starting a business, why not just invest in one? That is exactly what you can do for publicly traded cannabis companies. The sector has been hit with a significant amount of volatile trading over the years. But that has not stopped people from seeing the future possibilities with this burgeoning industry.
New Volusia County location will host grand opening celebration Friday, March 20 TALLAHASSEE, Fla., March 13, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S, today announced the opening of a new medical cannabis dispensary in DeLand, Florida.
Retail investors in r/options are making an unusual bet on AdvisorShares Pure US Cannabis ETF ( NYSEARCA:MSOS ), and the activity is hard to ignore.
New Polk County location will host grand opening celebration Friday, March 13 TALLAHASSEE, Fla., March 11, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S, today announced the opening of a new medical cannabis dispensary in Lake Wales, Florida.
